QQ客服 官方微博 反馈留言

浏览/检索结果: 共43条，第1-10条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 4 作者:  Domchek, Susan M.;  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 4 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 4 作者:  Li, Wei;  Im, Seock-Ah;  Xu, Binghe;  Robson, Mark;  Ouyang, Quchang 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 4 作者:  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe;  Masuda, Norikazu 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 4 作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study 期刊论文 MEDICINE, 2018, 卷号: 97, 期号: 21 作者:  Li, Junjie;  Shao, Zhimin;  Xu, Binghe;  Jiang, Zefei;  Cui, Shude 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05 adjuvant therapy  breast cancer  HER2-targeted therapy  neoadjuvant therapy  trastuzumab   Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China: A pooled retrospective analysis of four observational studies 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30, 期号: 3 作者:  Xu, Binghe;  Shao, Zhimin;  Wang, Shui;  Jiang, Zefei;  Hu, Xichun 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 Adjuvant chemotherapy  docetaxel  early-stage breast cancer   A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Design, Synthesis, and Biological Evaluation of Pyrazoline-Based Hydroxamic Acid Derivatives as AminopeptidaseN (APN) Inhibitors 期刊论文 CHEMMEDCHEM, 2018, 卷号: 13, 期号: 5, 页码: 431-436 作者:  Cao, Jiangying;  Zang, Jie;  Ma, Chunhua;  Li, Xiaoguang;  Hou, Jinning 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11 aminopeptidase N  anti-angiogenesis  antitumor agents  inhibitors  pyrazoline   Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy 期刊论文 2018, 卷号: 10, 页码: 3801-3808 作者:  Liao, Yuqian;  Liao, Yulu;  Li, Jun;  Li, Junyu;  Fan, Ying 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Aurora kinase  TNBC  polymorphism  prognosis